PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.100 Laboratory medicine>11.100.10 In vitro diagnostic test systems>BS EN ISO 20166-3:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue Isolated DNA
Sponsored link
immediate downloadReleased: 2019-01-28
BS EN ISO 20166-3:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue Isolated DNA

BS EN ISO 20166-3:2019

Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue Isolated DNA

Format
Availability
Price and currency
English Secure PDF
Immediate download
249.60 EUR
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
24.96 EUR
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
74.88 EUR
English Hardcopy
In stock
249.60 EUR
Standard number:BS EN ISO 20166-3:2019
Pages:26
Released:2019-01-28
ISBN:978 0 580 91925 1
Status:Standard
DESCRIPTION

BS EN ISO 20166-3:2019


This standard BS EN ISO 20166-3:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue is classified in these ICS categories:
  • 11.100.10 In vitro diagnostic test systems

This document gives guidelines on the handling, documentation, storage and processing of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for DNA examination during the pre-examination phase before a molecular assay is performed.

This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories and molecular pathology laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities.

NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.